Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Daily Summary: Time for a Correction (23.05.2026)
US Open: Are Markets Turning Away from AI?
Is the market turning away from technology?
Korean stocks retreat pressuring global sentiments 🚩What's next for US500?